Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment? - Wikidata - wikimedia - TriplyDB

Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment?

Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment?

http://www.wikidata.org/entity/Q36858180

about

Thymoma and autoimmunity.Antivenom for Neuromuscular Paralysis Resulting From Snake Envenoming.A functional SNP in the regulatory region of the decay-accelerating factor gene associates with extraocular muscle pareses in myasthenia gravis.RNA expression analysis of passive transfer myasthenia supports extraocular muscle as a unique immunological environment.Extraocular muscle characteristics related to myasthenia gravis susceptibility.Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity Differential RNA Expression Profile of Skeletal Muscle Induced by Experimental Autoimmune Myasthenia Gravis in Rats.Neuromuscular transmission failure in myasthenia gravis: decrement of safety factor and susceptibility of extraocular muscles.The extraocular muscle stem cell niche is resistant to ageing and disease.The African-387 C>T TGFB1 variant is functional and associates with the ophthalmoplegic complication in juvenile myasthenia gravis.A unique subphenotype of myasthenia gravis.Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies.

P2860

Q33577486-06CDAAEB-914F-4C44-BC61-48038EC52CB1 Q33612077-138DC2DD-EEFB-4A7A-A7DF-5621D794ADE8 Q33711147-9A6F9CD1-F3A8-4797-B85D-691B6627AEBC Q33915924-79A21D76-6208-45BE-9090-3E8D3366B97B Q34586123-D1EE5F2E-3A7D-49EA-A6F5-F7B383EF56DA Q37315963-2D9EDBC3-8965-49E7-BF83-E54963909C52 Q37405059-E6A26A3F-D558-480C-B55C-D7C48C4F8269 Q38070763-57978BBC-CC6E-4239-B521-31FCB27B8242 Q41674927-D6F357FC-45FF-43B8-92EE-A61A86A6C51F Q42485842-8F6BAA0C-8126-490A-8964-B5A73F216FE9 Q46527309-1C4E57ED-07D5-4022-8422-6994C4E105C5 Q54631945-DECD4D09-FF12-4083-AF02-E458B1DE287F

P2860

Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment?

http://www.wikidata.org/entity/Q36858180

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment?

@en

type

label

Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment?

@en

prefLabel

Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment?

@en

P1433

Q36858180-CC96EE97-BDC5-4E9D-A676-6792F8145EC0

P1476

Q36858180-D339577D-FA3F-421A-8E85-B3C08AC162E8

P2093

Q36858180-2496E349-B180-40C0-B349-BB85A73FFD81

Q36858180-58F089C6-1B10-4F88-A544-FAFD8763C281

Q36858180-76951639-40EC-4E7E-BC30-271C9B31F3B9

Q36858180-79F4D092-8AA0-4E76-9899-BA3FDC2535BE

Q36858180-E1ADB890-B17F-4DF8-A708-FAF80C81D8BA

P2860

Q36858180-00230629-FAF5-4217-8E79-B3BD94FD59C6

Q36858180-0B634EE0-ADB0-42F5-B8C8-C46CAE304486

Q36858180-0D06EC9D-E152-460B-95A1-0B6B0B3AD15F

Q36858180-16A103FB-2E24-4D27-A2B8-3961DD3AEEF8

Q36858180-1B58F258-2A2D-4216-B3AF-68BA21D94176

Q36858180-1F4DB1B1-A70D-4197-89F5-91ABF5B37C69

Q36858180-2C1A6D2B-FAFA-4130-A9B7-78F6C9FA6C32

Q36858180-30E70144-740F-4F7B-94CE-289922F29CC6

Q36858180-36D7577F-3EF9-4175-8481-C9E70A70DFC8

Q36858180-37549A82-005E-4152-8721-F613C1C37D83

P304

Q36858180-0E1E930D-8584-476D-A72D-A7414117331B

P31

Q36858180-22F03C67-89DB-4C16-9373-C91781DB772C

P356

Q36858180-8755D57D-37FC-4D55-A722-873741AB47AA

P407

Q36858180-1778661B-3002-4A19-8E94-E7DFDB2BF221

P478

Q36858180-1398A128-6D62-48FA-A4A7-ADEA430B093A

P577

Q36858180-A3B2BD70-319A-412C-BEC0-FE23FF1C3A86

P5875

Q36858180-38123187-782D-4559-A708-CFB4BB4EB621

P698

Q36858180-B4C5F769-DC20-4822-BDB4-B7577045A89C

P921

Q36858180-5E7DEF45-B112-4BB3-92ED-C8615A833322

P932

Q36858180-AF923E24-4BE4-4C2C-B280-95BEF48C8629

P356

ANNALS.1405.037

P1433

Annals of the New York Academy of Sciences

P1476

Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment?

@en

P2093

Bendi Gong

http://www.w3.org/2001/XMLSchema#string

Henry J Kaminski

http://www.w3.org/2001/XMLSchema#string

Jindrich Soltys

http://www.w3.org/2001/XMLSchema#string

Linda L Kusner

http://www.w3.org/2001/XMLSchema#string

Yuefang Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Myasthenia gravis: past, present, and future

CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells

Complement. First of two parts

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

Extraocular muscle is defined by a fundamentally distinct gene expression profile.

Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis.

Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases.

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.

Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.

Effect of complement and its regulation on myasthenia gravis pathogenesis.

P304

220-224

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1196/ANNALS.1405.037

http://www.w3.org/2001/XMLSchema#string

P407

P478

1132

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5288461

http://www.w3.org/2001/XMLSchema#string

P698

18567871

http://www.w3.org/2001/XMLSchema#string

P921

myasthenia gravis

P932

2527818

http://www.w3.org/2001/XMLSchema#string